Skip to main content
. 2022 Jul 13;9:870200. doi: 10.3389/fcvm.2022.870200

Table 7.

CMR offerings to the PM/DM.

Cardiac manifestation CMR utility Sequences
What has CMR to offer in polymyositis/dermatomyositis?
Valvular heart disease Assessment of hemodynamic significance.
Reproducible follow-up.
Cine—SSFP, cine-FGE
PhC, 4D-flow
Pulmonic hypertension The severity and hemodynamic significance.
Orientation to the potential etiology.
Cine—SSFP
Real-time cine
4D-flow
MRA
Myocardial edema Identification and quantification
Follow up
T2-W, T2-W-STIR
T2-mapping
Myocarditis Identification and quantification.
Follow up free of radiation.
T2-W-STIR
T1, T2-mapping, ECV
LGE-PSIR
Myocardial inflammation Identification and quantification.
Follow up free of radiation.
T1-W pre, and post-Gd
T1 mapping, ECV
LGE-PSIR
RV dysfunction The gold standard for RV function Cine—SSFP
Strain
LV dysfunction The gold standard for LV function Cine—SSFP
Strain, diffusion tensor

SSFP, steady-state free precession; FGE, fast gradient echo; T2-W, T2-weighted; STIR, short tau inversion recovery; LGE, late gadolinium enhancement; PSIR, Phase-sensitive inversion recovery; ECV, extracellular volume; MRA, magnetic resonance angiography; Gd, gadolinium.